Table 1. Patient Characteristics.
Characteristics | Value (%) |
Patients | N=18 |
Median age (yrs) | 47.8 |
Median KPS | 90 |
Sex | |
Male | 8 (44) |
Female | 10 (56) |
Primary head and neck tumor site | |
Nasopharynx | 6 (33) |
Sinonasal | 3 (17) |
Parotid | 3 (17) |
Hard palate | 2 (11) |
Unknown primary | 2 (11) |
Buccal mucosa | 1 (6) |
Infratemporal fossa | 1 (6) |
Histology | |
Squamous cell carcinoma | 5 (28) |
Adenocarcinoma | 2 (11) |
Adenoid cystic carcinoma | 7 (39) |
Undifferentiated | 4 (22) |
Primary treatment | |
Surgery + concurrent chemotherapy and EBRT | 2 (11) |
Concurrent chemotherapy and EBRT | 5 (28) |
Surgery + EBRT | 11 (61) |
Recurrent treatment site | |
Dura | 2 (11) |
Nasopharynx | 3 (17) |
Skull base | 7 (39) |
Sinonasal | 2 (11) |
Cavernous sinus | 4 (22) |
SRS dose (median) | 13.3 Gy |
Time from EBRT to SRS (median months) | 23.7 |